Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: phoenix_rising who wrote (1349)	6/29/2015 8:40:53 PM
From: mokelumne river	1 Recommendation Recommended By Mirror Image Read Replies (2) \| Respond to of 2026

Here is the email I just received: Gentlemen, Our representation of Apricus draws to a close tomorrow as The Trout Group assumes the leadership of APRI’s IR program across all constituencies. They are an excellent firm with a strong health care reputation, and I’m sure they will do a great job supporting the IR program, including building a beachhead in Europe. Matt & Brian will lead the charge and their emails are above and Brian’s contact info is below. I know they will be highly responsive to your questions, concerns and suggestions so don’t be shy - not that any of you are! We’ve greatly enjoyed our involvement with the APRI program and working with you over the past 9 months. While we are sorry to part ways with the Company, I do think it’s appropriate that APRI consolidate its IR effort into the resources of one firm, reduce its related costs and improve the transparency of its IR effort. We have stressed the importance of APRI’s retail base to its current and future valuation as it works to further institutionalize its investor base - and are confident they will pick up where we left off - applying a few Vitaros doses to the equity valuation! We hope to remain in touch with you on other current and future investments and wish you all the best in the future. Keep those client referrals a comin’! Best regards, David, Chris & Tanya